Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Vitalmax Vitamins
WARNING LETTER
•Vitalmax Vitamins•January 31, 2013

Vitalmax Vitamins – FDA Warning Letter, Jan 31, 2013

Record Details

This FDA Warning Letter, issued in January 2013, addresses Vitalmax Vitamins' marketing of "BodyGuard" on www.vitalmaxvitamins.com and www.healthyanswers.com. The FDA determined that BodyGuard, labeled as a dietary supplement, is marketed with claims to diagnose, mitigate, prevent, treat, or cure the Flu Virus, rendering it an unapproved new drug.

Specific violations include claims like "Boost Your Immune System and Fight Cold and Flu - Naturally!" and "Safeguard you from deadly flu viruses." These claims cause the product to be considered a "new drug" under section 201(p) of the FFDC Act [21 U.S.C. § 321(p)], requiring FDA approval based on scientific data for safety and effectiveness. Since the product is for conditions not amenable to self-diagnosis and treatment, it is also misbranded under section 502(f)(1) [21 U.S.C. § 352(f)(1)] due to inadequate directions for layperson use.

The letter demands immediate cessation of marketing unapproved products for Flu Virus treatment. Vitalmax Vitamins must email FDA within 15 days, detailing corrective actions. Failure to comply may result in enforcement actions like seizure, injunction, or criminal prosecution. The FTC also warns against unsubstantiated claims, requiring competent and reliable scientific evidence, and requests notification within 15

Company
Vitalmax Vitamins
Inspection date
January 31, 2013
Product type
Food
Office
Center for Food Safety and Applied Nutrition
People
  • Mary K. Engle (Associate Director)
  • Michael W. Roosevelt (Program Division Director)
View Company Profile

ID · 64d765ab-6a63-4fa6-91a0-e381eec50bbb

Violation Codes6
21 U.S.C. 33121 U.S.C. 35221 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vitalmax Vitamins
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.